Detalhe da pesquisa
1.
A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement.
N Engl J Med
; 382(2): 120-129, 2020 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31733180
2.
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer.
N Engl J Med
; 380(8): 720-728, 2019 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30786186
3.
Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI.
N Engl J Med
; 375(25): 2423-2434, 2016 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-27959713
4.
Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy.
Circulation
; 135(4): 323-333, 2017 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-27881555
5.
Safety and efficacy of non-vitamin K oral anticoagulant for atrial fibrillation patients after percutaneous coronary intervention: A bivariate analysis of the PIONEER AF-PCI and RE-DUAL PCI trial.
Am Heart J
; 203: 17-24, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30015064
6.
Total bleeding with rivaroxaban versus warfarin in patients with atrial fibrillation receiving antiplatelet therapy after percutaneous coronary intervention.
J Thromb Thrombolysis
; 46(3): 346-350, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29943350
7.
Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study.
Am Heart J
; 184: 81-87, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27892890
8.
Shortened hospital length of stay and lower costs associated with rivaroxaban in patients with pulmonary embolism managed as observation status.
Int J Clin Pract
; 71(1)2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28097761
9.
Observation management of pulmonary embolism and agreement with claims-based and clinical risk stratification criteria in United States patients: a retrospective analysis.
BMC Pulm Med
; 17(1): 37, 2017 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-28193193
10.
Outcomes associated with observation stays versus inpatient admissions for pulmonary embolism.
J Thromb Thrombolysis
; 42(4): 513-9, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27324143
11.
Prevention of Bleeding in Atrial Fibrillation.
N Engl J Med
; 376(10): 994, 2017 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28273012
12.
An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin K antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention (PIONEER AF-PCI).
Am Heart J
; 169(4): 472-8.e5, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25819853
13.
Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation.
Eur Heart J
; 35(47): 3346-55, 2014 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-25182247
14.
Rationale and design of the eXplore the efficacy and safety of once-daily oral riVaroxaban for the prEvention of caRdiovascular events in patients with nonvalvular aTrial fibrillation scheduled for cardioversion trial: A comparison of oral rivaroxaban once daily with dose-adjusted vitamin K antagonists in patients with nonvalvular atrial fibrillation undergoing elective cardioversion.
Am Heart J
; 167(5): 646-52, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24766973
15.
Biomarker signatures in cancer patients with and without venous thromboembolism events: a substudy of CASSINI.
Blood Adv
; 6(4): 1212-1221, 2022 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34807979
16.
Comparative Risk Assessment of Severe Uterine Bleeding Following Exposure to Direct Oral Anticoagulants: A Network Study Across Four Observational Databases in the USA.
Drug Saf
; 44(4): 479-497, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33651368
17.
Rivaroxaban thromboprophylaxis for gastric/gastroesophageal junction tumors versus other tumors: A post hoc analysis of the randomized CASSINI trial.
Res Pract Thromb Haemost
; 5(5): e12549, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34308096
18.
Assessing Full Benefit of Rivaroxaban Prophylaxis in High-Risk Ambulatory Patients with Cancer: Thromboembolic Events in the Randomized CASSINI Trial.
TH Open
; 4(2): e107-e112, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32462111
19.
Rivaroxaban thromboprophylaxis in ambulatory patients with pancreatic cancer: Results from a pre-specified subgroup analysis of the randomized CASSINI study.
Cancer Med
; 9(17): 6196-6204, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32663379
20.
Novel Oral Anticoagulant Based Versus Vitamin K Antagonist Based Double Therapy Among Stented Patients With Atrial Fibrillation: Insights From the PIONEER AF-PCI Trial.
Circ Cardiovasc Interv
; 12(11): e008160, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31707805